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contrast agents for in vivo photoacoustic molecular
imaging
Liming Nie,ab Mei Chen,c Xiaolian Sun,a Pengfei Rong,a Nanfeng Zheng*c
and Xiaoyuan Chen*aA stable and efficient contrast agent is highly desirable for photo-
acoustic (PA) imaging applications. Recently gold nanostructures have
been widely reported and studied for PA imaging and photothermal
therapy. However, the structures of the nonspherical gold nano-
particles are easily destroyed after laser irradiation and thus may fail to
complete the intended tasks. In this study, we propose to apply
palladium nanosheets (PNSs), with strong optical absorption in the
near-infrared (NIR) region, as a new class of exogenous PA contrast
agents. PA and ultrasound (US) images were acquired sequentially by a
portable and fast photoacoustic tomography (PAT) system with a
hand-held transducer. Significant and long-lasting imaging enhance-
ment in SCC7 head and neck squamous cell carcinoma was
successfully observed in mice by PAT over time after tail vein admin-
istration of PNSs. The morphology and functional perfusion of the
tumors were delineated in PA images due to the nanoparticle accu-
mulation. PAT of the main organs was also conducted ex vivo to trace
the fate of PNSs, which was further validated by inductively coupled
plasma atomic emission spectrometry (ICP-AES). No obvious toxic
effect was observed by in vitro MTT assay and ex vivo histological
examination 7 days after PNS administration. With the combination of
a portable imaging instrument and signal specificity, PNSs might be
applied as stable and effective agents for photoacoustic cancer
detection, diagnosis and treatment guidance.Introduction
At present, tissue biopsy is the most common way to accurately
diagnose cancer. Having a noninvasive imaging method that
could diagnose/image tumors would bring considerable benet
to patients by reducing unnecessary biopsies and surgeries.omedicine (LOMIN), National Institute of
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hemistry 2014Photoacoustic tomography (PAT) with the aid of optimal exog-
enous contrast agents is very promising for diagnosis and
visualization of supercial lesions such as the head and neck
squamous cell carcinoma. Noninvasive and nonionizing PAT
can potentially offer a painless diagnostic way to reduce the
physical pain and emotional stress that a biopsy may cause.
PAT has been extensively studied in various biomedical
applications to provide in vivo structural, functional, and
molecular images.1–3 The instrumentation of PAT has been
implemented by several modalities, including photoacoustic
microscopy,4 full-ring ultrasonic array PAT,5 and hemispherical
array photoacoustic imaging.6 The imaging specicity has
always been an attractive research interest in PAT because
function imaging is desired to monitor physiological dynamics
with high contrast.
In order to enable the visualization of many other
biomarkers besides hemoglobin and melanin, exogenous
contrast agents were demonstrated to improve PAT imaging
contrast and specicities.7–11 Among these enhancing nano-
particles, gold nanostructures have been extensively reported
and studied in PAT.12–14 However, fabrication of a promising
sensor candidate for optical monitoring still remains a great
challenge since gold conjugates are very susceptible to heat/
temperature rise. Stability of the administrated agents is an
issue for continuous optical monitoring. Once melted, the
particles will no longer be effective and will lose their functions
for imaging or therapy purposes. For instance, gold nanorods
begin to collapse dramatically aer several minutes of laser
irradiation with moderate energy.12 Previously, palladium (Pd)
nanosheets (PNSs) were reported to have high photothermal
efficiency and catalytic properties.15,16 Because of the high
photothermal stability and ultrathin structure, PNSs hold great
potential for imaging enhancement and cellular permeability in
the biological system. However, to the best of our knowledge,
the use of Pd for optical diagnostic imaging has never been
reported.
In this study, we utilized a photoacoustic and ultrasound














































View Article Onlineacquisition, which is highly translatable into clinical medicine.
For the rst time, we applied PNSs as contrast agents with PAT
for in vivo tumor perfusion visualization. The optical absorption
and morphology changes of the PNSs versus gold nano-
structures due to laser excitation were monitored by UV-vis-NIR
spectroscopy and transmission electron microscopy (TEM),
respectively. Aer 5 min laser irradiation at80 mW cm2, gold
nanorods collapsed dramatically in structure and aggregated
quickly. In contrast, the structure of PNSs remained almost
unchanged even aer 10 min laser irradiation. The tumor
accumulation of the unique nanosheets is demonstrated on a
head and neck squamous cell carcinoma (SCC7) xenogra
model. Furthermore, the biodistribution of PNSs in different
organs was measured ex vivo by PAT, which was validated by
inductively coupled plasma atomic emission spectrometry (ICP-
AES). In vitro MTT assay and ex vivo hematoxylin and eosin
(H&E) staining were conducted to validate the nontoxicity of
PNSs. Our study demonstrates that PNSs may be used as stable
and effective agents for molecular photoacoustic imaging,
which would greatly benet early stage carcinoma evaluation,
image-guided resection, and highly sensitive and specic
staging.
Methods and materials
A high-resolution small-animal imaging system (Vevo LAZR
2100, VisualSonics, Canada) was employed for both ultrasound
and photoacoustic imaging. A 256-element linear array trans-
ducer with a center frequency of 21 MHz was aligned to position
the 10mm focal depth in the center of the target. Ultrasound gel
(Parker Laboratories, NJ), which does not produce any PA
signal, was applied to the tissue surface for ultrasound signal
coupling. Light from a tunable laser from 680–970 nm was
delivered through an optical ber bundle as the excitation
source. A ltered back-projection algorithm was employed to
reconstruct the PAT images.17,18 The laser energy was recorded
simultaneously to calibrate the laser energy uctuation. Mice
tumors were imaged using 790 nm laser light, before and aer
PNS probe injection. Ultrasound and PA images were obtained
sequentially, and then overlapped into one image. The US
image depicts the anatomy of the target while the PAT image
reects the functional optical absorption contrast.
To synthesize 16 nm palladium nanosheets, Pd(II) acetyla-
cetonate (Pd(acac)2, 10.0 mg), poly(vinylpyrrolidone) (PVP, MW
z 30 000, 30.0 mg) and NaBr (10.2 mg) were mixed together
with N,N-dimethylvaleramide (2 mL) and water (4 mL) in a glass
pressure vessel. The vessel was then charged with CO to 1 bar
and heated at 60 C for 3.0 h before it was cooled to room
temperature. The mixture was kept at 4 C overnight before
centrifugation. The dark blue product was precipitated by
acetone, separated by centrifugation and then puried using an
ethanol–acetone mixture. The 16 nm hexagonal nanosheets
exhibit absorption peaks at 790 nm.19 The PNSs can be main-
tained in ethanol at 0 C and still retain their NIR absorption
characteristics even aer several months. When used, the as-
prepared dark blue solution was precipitated by acetone and
separated via centrifugation at 10 000 rpm for 2 min. Aer1272 | Nanoscale, 2014, 6, 1271–1276centrifugation, the collected particles were dried by thorough
lyophilization. Then the products were redispersed in water for
imaging purposes. Photoacoustic and ultrasound imaging of
tumors on two groups of mice were performed by injecting each
with 200 mL of either PBS or 0.8 mg mL1 PNS. All other
chemicals were purchased from Sigma-Aldrich (St. Louis, MO,
USA) unless stated otherwise.
Immunodecient nude mice weighing 21 g were used for
the animal experiments. The SCC7 cells were cultured under
standard conditions and inoculated subcutaneously into the
shoulder of the mice (106 cells per mouse). In vivo PAT and
ultrasound imaging were performed 2 weeks aer tumor growth
with a diameter of 0.9–1.3 cm. The mice were anesthetized
with 1–2% isourane during experiments. The body tempera-
ture of the mice was maintained using a water heating system at
38 C. Aer imaging, the mice were sacriced and organs were
harvested for biodistribution analysis of palladium by induc-
tively coupled plasma atomic emission spectroscopy (ICP-AES).
The ICP results were acquired from a JY2000 Ultrace ICP atomic
emission spectrometer equipped with a JY AS 421 autosampler
and 2400 g mm1 holographic grating. Samples (n ¼ 5 per
tissue) for ICP-AES analysis were lyophilized, and dissolved in
aqua regia under minor stirring for 12 h until the palladium
particles were fully dissolved.20 The aqua regia was prepared
with 100 mL of nitric acid and 300 mL of 37% hydrochloric acid.
Then the samples were diluted to 10 mL with 9.6 mL of 2%
HNO3 and analyzed via ICP-AES.
The in vitro cytotoxicity of PNSs was analyzed using a stan-
dard methyl thiazolyl tetrazolium (MTT, Sigma-Aldrich) assay.
SCC7 cells were seeded into a 96-well plate at a density of 104
cells per well and then incubated at 37 C for 24 h under 5%
CO2. Aer incubating SCC7 cells with PNSs at various concen-
trations for 24 h, the standard MTT assay was carried out to
determine the cell viability relative to the control untreated
cells. For H&E staining, mice injected with either PBS (control)
or PNSs (20 mg kg1) were sacriced at 7 days post-injection.
Major organs were harvested and sectioned into thin slices for
histological analysis. All animal procedures were approved by
the Institutional Animal Care and Use Committee of the Clin-
ical Center, National Institutes of Health.
Results and discussion
The photothermal properties of gold nanorods (GNRs) and
PNSs aer various periods of laser irradiation were investigated
by UV-vis-NIR spectra measurement. The tested GNRs were well
dispersed in water with an aspect ratio of 3 : 1. The UV-vis-NIR
spectra of GNRs were acquired before, 5, 10, and 15 min aer
laser irradiation (Fig. 1a). The laser energy was 4 mJ per cm2
per pulse with a repetition rate of 20 Hz, which is the energy
source for PAT. Aer 5 min laser irradiation, the spectrum curve
changed to a plateau and the relative absorption peak dropped
sharply from nearly 1.0 to less than 0.2. Over the next 10 min of
irradiation there was further smoothing to the absorption
curve. There was also a shi in peak absorption towards shorter
wavelengths within the rst 5 min, from 850 nm to740 nm. In
contrast, the absorption spectra of PNSs remained almostThis journal is © The Royal Society of Chemistry 2014
Fig. 1 (a) Absorption spectra of gold nanorods (GNRs, 3 : 1 aspect ratio) before, 5, 10, and 15 min after laser irradiation. (b–d) TEM images of the
GNRs (b) before, (c) 5 min, and (d) 10 min after pulsed laser irradiation. (e) Absorption spectra of palladium nanosheets (PNSs) before and 10 min
after laser irradiation. (f–h) TEM images of the PNSs (f) before, (g) 5 min, and (h) 10 min after pulsed laser irradiation. The pulsed laser was set at
4 mJ per cm2 per pulse with a repetition rate of 20 Hz.
Fig. 2 (a) Size distribution of palladium nanosheets (PNSs) measured
by dynamic light scattering (DLS) before and 10 min after pulsed laser
irradiation (4 mJ per cm2 per pulse with a repetition rate of 20 Hz). (b)
Linear regression plot of the relative PA signal intensity and PNS
concentration. The error bars represent standard error (n ¼ 4 per
group). The original PA image for each concentration was also dis-














































View Article Onlineunchanged with slight broadening 10min aer laser irradiation
(Fig. 1e). Specically, the relative optical extinction uctuated by
less than 0.1% aer 10 min of irradiation, as compared to the
initial value.
Correspondingly, TEM images of GNRs before, 5 min, and
10 min aer laser irradiation are displayed in Fig. 1b–d,
respectively. It is interesting to observe that during the irradi-
ation period, a shorter and rounder structure takes the place of
the distinct long and rod shape of the GNS. Moreover, the gold
nanoparticles aggregated and accreted severely to exhibit dark
‘spots’ in the TEM images. Since the plasmonic resonance is
determined by the molecular conformation, the optical absor-
bance differences depicted in Fig. 1a can be explained by the
morphological change caused by laser irradiation. However, in
comparison, there was hardly any change in the PNS shape
during the irradiation period, as shown in the TEM images of
Fig. 1f–h. Compared to GNRs, PNSs are much more stable at
maintaining both their morphology and peak absorption
throughout the laser irradiation. The results in Fig. 1 demon-
strate that the as-prepared palladium compound is ideally
stable under long-term laser irradiation.
The dynamic light scattering (DLS) method was also
employed to further validate the phothermal stability of PNSs
(Fig. 2a). The hydrodynamic size of PNSs aer 10 min laser
irradiation with a pulse energy of 4 mJ cm2 was very similar to
that before laser irradiation, corroborating with the UV-vis-NIR
and TEM results. The PA signal as a function of nanoparticle
concentration is shown in Fig. 2b. PNS solutions were lled in
transparent thin tubes. Note that both the top and bottom
boundaries of the tubes were clearly delineated in the PAT
images because the 21 MHz ultrasonic transducer ltered out
the low-frequency components from the center of the tubes. A
strong linear relationship (n ¼ 4 per group, R2 ¼ 0.995) was
found between the produced PA signal intensity and the
concentration of PNSs.
PAT and ultrasound images of two groups of mice (n ¼ 5 per
group) bearing SCC7 xenogras were acquired at 2, 4, 6, 8, andThis journal is © The Royal Society of Chemistry 201424 h aer tail vein injection of either PBS (200 mL) or PNSs
(200 mL, 0.8 mg kg1) (Fig. 3). The PAT image displayed in color
and the ultrasound image displayed in gray were overlayed for
each time point. The 790 nm laser with moderate laser energy
at 4 mJ cm2 was used for PA probe detection. As shown in
Fig. 3a, only tumor skin produced PA signals on the surface of
the mice injected with PBS, which is attributable to the shallow
penetration depth and low absorption contrast in the tumor.Nanoscale, 2014, 6, 1271–1276 | 1273
Fig. 3 Photoacoustic and ultrasound images of tumors on two mice
groups injected intravenously with 200 mL of (a) PBS and (b) 0.8 mg
mL1 PNS solutions acquired at 0, 2, 4, 6, 8, and 24 h post-injection,
respectively. The arrows show more features in the tumor enhanced
by the Pd agents. Scale bar ¼ 5 mm. (c) Quantified PA signal in the
tumors injected with PBS and PNSs acquired before, 2, 4, 6, 8, and 24 h
after injection. The PA signals in each group were self-normalized for
comparison between two groups. The error bars represent standard














































View Article OnlineHowever, the image contrast of the tumor in Fig. 3b injected
with PNSs gradually increased, indicating that a signicant
amount of PNSs were gradually accumulating into the tumor to
enhance the visibility. The ultrahigh tumor accumulation of
PNSs is likely due to the enhanced permeability and retention
(EPR) effect in cancerous tumors with tortuous and leaky
vasculatures. Most importantly, with the aid of PNSs, the lower
boundary of the tumor was unveiled in the images, which
could be potentially used for guiding surgery.
In each image, PA signals were selected and quantied
within an identical region of interest (ROI) with a diameter of
1 cm. The average value of the calculated PA signals was
shown to evaluate the variation of nanoparticle accumulation
in the tumor area (Fig. 3c). The PA signals in each group were
self-normalized for comparison between two groups.1274 | Nanoscale, 2014, 6, 1271–1276Specically, the PA signals at different time points were
divided by the PA signal before injection. The red line repre-
sents the group injected with PNSs while the blue line repre-
sents the group injected with pure PBS. For the PNS group, the
PA signal achieved in the tumor is 3.5-fold greater than the
original signal and reached a steady level even aer 24 h.
Statistical signicance between the two groups was assessed at
each time point using a two-tailed Student's t-test. It indicates
that PNSs produced a more persistent and efficient PAT
enhancement (*, P < 0.01). The results suggest that the
molecular specic PAT with plasmonic Pd nanocrystals could
be used to enhance the embedded tumor and uncover the
boundaries.
To trace the fate of PNSs in the mice, ex vivo PAT at 790 nm
was carried out on the main organs of the two mice groups
(n ¼ 5 per group) before and 24 h aer PNS injection (200 mL,
0.8 mg mL1). The photos of the organs (liver, spleen, heart,
lung, and kidney) are shown in Fig. 4a. PAT images of the
organs from the mice before and 1 day aer injection with
PNSs are shown in Fig. 4b and c, respectively. As can been
seen, the liver has more palladium deposition, which is about
4 times higher than that in the spleen and lung. The results of
this ex vivo study may uctuate due to surgical procedures,
laser wavelength, blood distribution in the organs, etc.
However, the method could be useful for quick measurement
in animal studies especially when the direct measurement is
not possible.
Furthermore, the biodistribution of Pd in the organs 24 h
aer injection was measured by ICP-AES. The statistical results
with standard deviations are shown in Fig. 5a. The liver has the
highest accumulation, which is consistent with the PA
measurement result. The tumor contained the second highest
palladium concentration, which was also observed with the
positive PA signal amplication in the tumor. The other
organs, such as the kidneys, heart, spleen, and lung, also had
some accumulation of Pd. The nanoparticle accumulation
variations on the organs depend on the particle properties
(size, surface modication, shape, structure, charge, etc.) and
experimental design (animal model, dosage, method and time
schedule of administration, observation time, etc.).21,22 There-
fore, further careful and comprehensive studies of nano-
biosafety are needed to determine the biodistribution–
accumulation–retention–clearance effects of PNSs and their
roles in toxicity.
As illustrated in Fig. 5b, the viabilities of cells exposed to
various concentrations of PNSs show a similar pattern to that
of the control cells, indicating that PNSs below the concen-
tration of 1 mg mL1 are essentially non-toxic to SCC7 cells.
Since the Pd nanoparticles were entrapped in the liver and
spleen indicated by ICP-AES, macrophages in the liver (Kupffer
cells) and spleen were assumed to have absorbed the majority
of the nanoparticles. However, the histological image of the
hepatic lobules did not display an elevated number of Kupffer
cells 7 days aer PNS injection compared to PBS control
(Fig. 5c). Macrophages in the marginal area of the spleen did
not show any apparent change, either. Mesangial cell prolif-
eration with expansion is usually observed inThis journal is © The Royal Society of Chemistry 2014
Fig. 4 Ex vivo PAT of the main organs before and 24 h after tail vein injection of PNSs (200 mL, 0.8 mg mL1). (a) Photograph of the organs
(kidney, heart, liver, spleen, and lung). (b) PAT images of the organs from themice before injection of PNSs. (c) PAT images of the organs from the














































View Article Onlineglomerulonephritis. However, we did not observe obvious
change in the number of positively stained mesangial cells in
the kidneys of mice injected with PNSs compared with PBS
control. No noticeable abnormality was observed in major
organs including kidneys, heart, liver, spleen, lung, stomach
and intestine. Although our preliminary data here showed that
PNSs could offer good biocompatibility, future experiments are
still needed to interpret the long-term fate, clearance pathways,
and toxicology of PNSs in animals.
Owing to the signicantly higher bulk melting point
(MPPd ¼ 1828 K versus MPAu ¼ 1337 K, and MPAg ¼ 1235 K),
PNSs, in principle, should possess improved photothermal
stability over gold and silver nanostructures. Furthermore, theFig. 5 (a) Biodistribution of Pd in main organs (kidneys, heart, liver, splee
0.8 mg mL1) acquired by ICP-AES. (b) SCC-7 cell viability after 48 h exp
major organs of nude mice 7 days after administration of PBS (control) o
organs including kidneys, heart, liver, spleen, lung, stomach, and small in
This journal is © The Royal Society of Chemistry 2014unique nanosheets have a large surface area because of their
ultrathin character (<10 atomic layers thick),15,23 which could
be used for high-loading drug delivery. Although PNSs may be
possibly excreted via both fecal and renal clearance, better
understanding of long-term toxicology and quantitative phar-
macokinetics is important and requires further investigations.
Previous studies indicate that nanoparticles with a size of
dozens of nanometers may exhibit higher tumor accumulation
ability than bigger nanoparticles due to their minimal recog-
nition by the liver and spleen macrophages,24,25 which
encouraged us to apply 16 nm PNSs in this study. More
systematic investigations on PNSs with larger sizes are
currently underway.n, tumors and lung) of the mice at 24 h post-injection of PNSs (200 mL,
osure to PNSs at different concentrations. (c) H&E staining of various
r PNSs (20 mg kg1). No noticeable abnormality was observed in major
testine.















































In summary, we demonstrated the feasibility of palladium
nanosheets (PNSs) as a novel class of probes for in vivo tumor
perfusion imaging. The tumor morphology and boundaries
were greatly enhanced in the PAT images, suggesting that PNSs
can produce a stable and effective means for optical tumor
labeling and visualization. Currently only 4 mJ per cm2 per
pulse energy is used, which is well below 20 mJ per cm2, the
safety standard set by the American National Standards Insti-
tute (ANSI).26 Therefore, with relatively strong laser energy for
deeper tissue penetration, quantitative measurement of nano-
particle accumulation in vivo by PAT will be possible in the
future. Moreover, our PA/US system is highly mobile and does
not require complicated alignment. It takes only 0.05 second (20
Hz) to acquire one PAT image with a real-time ultrasound
image, which is fast enough to catch the most physiological
changes in the tumor.
Since the tumor has the second highest PNS accumulation
next to the liver in our study, the imaging strategy may also be
used for ex vivo differentiation and characterization of malig-
nant tumors. We believe that the proposed PNS formula and
imaging method are very promising for photoacoustic imaging
of tumors.
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